Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents+BCL2 inhibitor venetoclax
Li, Danyang; Yuan, Yigang; Meng, Chen; Lin, Zihan; Zhao, Min; Shi, Liuzhi; Li, Min; Ye, Daijiao; Cai, Yue; He, Xiaofei; Ye, Haige; Zhou, Shujuan; Zhou, Haixia; Gao, Shenmeng Share Save Share Save Share Save Share Save Share Save Share Save Share Save Share Save DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclaxYe, Sisi; Xiong, Fang; He, Xiaofei; Yuan, Yigang; Li, Danyang; Ye, Daijiao; Shi, Liuzhi; Lin, Zihan; Zhao, Min; Feng, Shuya; Zhou, Bin; Weng, Huachun; Hong, Lili; Ye, Haige; Gao, Shenmeng Share Save NLRP3-dependent microglial training impaired the clearance of amyloid-beta and aggravated the cognitive decline in Alzheimer's disease (vol 11, 849, 2020)He, Xiao-fei; Xu, Jing-hui; Li, Ge; Li, Ming-yue; Li, Li-li; Pei, Zhong; Zhang, Li-ying; Hu, Xi-quan Share Save Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
